Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study is designed to verify the safety and efficacy of Lepu® NeoVas™ Bioabsorbable Coronary Artery Rapamycin-eluting Stent System combined with different antiplatelet therapies in the treatment of coronary heart disease.
Epistemonikos ID: e7e82bfd5ca55800099eb789b8f472ab5f677109
First added on: May 09, 2024